PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Protagenic Therapeutics, Inc.\new
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026
Market cap
$1.36M
P/E (TTM)
–
Dividend yield
–
Protagenic Therapeutics, Inc.\new statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Market Cap
$1.36M
$166.30M
Enterprise Value
$791.67K
$87.12M
PB Ratio
0.79
2.03
Income (trailing twelve months)
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Revenue
$0
$57.94M
Operating Income
-$5.70M
-$21.49M
Pretax Income
-$5.53M
-$14.72M
Net Income
-$5.53M
-$22.46M
EBITDA
-$5.70M
-$17.14M
EPS (Diluted)
-$15.82
-$0.83
Returns
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Return on Equity (ROE)
-320.6%
-53.2%
Return on Assets (ROA)
-197.6%
-41.0%
Return on Invested Capital (ROIC)
-389.1%
-32.2%
Return on Capital Employed (ROCE)
-330.8%
-38.0%
Balance sheet
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Cash & Short-Term Investments
$565.99K
$62.64M
Net Cash (Debt)
$565.99K
$15.77M
Net Cash Per Share
$0.31
$0.66
Equity (Book Value)
$1.72M
$48.61M
Book Value Per Share
$0.95
$1.36
Tangible Book Value
-$356.50K
$23.01M
Working Capital
-$362.74K
$75.09M
Financial position
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Current Ratio
0.66
3.30
Quick Ratio
0.53
2.39
Cash flow (trailing twelve months)
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Operating Cash Flow
-$4.22M
-$12.39M
Efficiency
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Asset Turnover
0.00
0.38
Revenue Per Employee
$0
$398.96K
Profits Per Employee
-$1.84M
-$705.27K
Employee Count
3
74
Dividends and yields
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Earnings Yield
-407.0%
-22.8%
Shares
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Shares Outstanding
1,810,210
58,139,000
Float
1,468,440
49,154,900
Shares Held by Insiders
18.9%
11.6%
Shares Held by Institutions
3.69%
59.4%
Scores
Measure
Protagenic Therapeutics, Inc.\new
Industry median
Altman Z-Score
-8.63
-0.27
Piotroski F-Score
1
4
Calculated by StockData from Protagenic Therapeutics, Inc.\new's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.